Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 1;10(12):1854.
doi: 10.3390/nu10121854.

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness

Affiliations

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness

Luigi Barrea et al. Nutrients. .

Abstract

Neuroendocrine tumors (NETs) are rare neoplasms mostly originating from the gastroenteropancreatic tract (GEP-NETs). Data regarding nutritional status in GEP-NET patients are limited. The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet (MD) in GEP-NET patients and to correlate them with tumor aggressiveness. A cross-sectional case-control observational study was conducted enrolling 83 patients with well-differentiated G1/G2 GEP-NETs after resection, as well as 83 healthy subjects, age, sex and body mass index-matched. Nutritional status was assessed by evaluating with Bioelectrical Impedance analysis and its phase angle (PhA), adherence to the MD according to PREDIMED score, dietary assessment, anthropometric parameters, and clinico-pathological characteristics. GEP-NET patients consumed less frequently vegetables, fruits, wine, fish/seafood, nuts, and more frequently red/processed meats, butter, cream, margarine, and soda drinks than controls. Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1, localized and free/stable disease status. A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor, metastases, and progressive disease. To the best of our knowledge, this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP-NETs. Moreover, higher intakes of food of MD, may represent a potential tool for prevention of tumor aggressiveness. Thus, a skilled nutritionist should be an integral part of the multidisciplinary management of GEP-NET patients.

Keywords: Mediterranean diet; bioelectrical impedance analysis; gastroenteropancreatic neuroendocrine tumors; nutrition; tumor aggressiveness.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of the studied subjects. A total of 83 patients affected by well differentiated GEP-NET G1/G2 selected from 172 patients with NET attending the ENETS Centers of Excellence Multidisciplinary Group for Neuroendocrine Tumors, University “Federico II”, Naples. Abbreviation: NET, Neuroendocrine Tumor; GEP-NET, Gastroenteropancreatic NET; MTC, medullary thyroid cancer; Pheo/PPG, Pheochromocytoma/paraganglioma; ENETS, European Neuroendocrine Tumor Society.
Figure 2
Figure 2
Adherence to the Mediterranean Diet according to PREDIMED categories in GEP-NET patients classified by tumor grade G1/G2 (A), stage (B), and disease status (C). Abbreviation: GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor; PREDIMED, PREvención con DIeta MEDiterránea; MD, Mediterranean Diet.
Figure 3
Figure 3
ROC analysis was performed to determine the cut off values of the PREDIMED score (A) and PhA (B) predictive for the evaluation of increased risk of grading G2 Abbreviation: PREDIMED, PREvención con DIeta MEDiterránea; PhA, phase angle; ROC, Receiver operator characteristic.
Figure 4
Figure 4
ROC analysis to determine the cut off values of the PREDIMED score for the evaluation of increased risk of metastases (A) and progressive disease (B). Abbreviation: PREDIMED, PREvención con DIeta MEDiterránea; PhA, phase angle; ROC, Receiver operator characteristic.

References

    1. Dasari A., Shen C., Halperin D., Zhao B., Zhou S., Xu Y., Shih T., Yao J.C. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol. 2017;3:1335–1342. doi: 10.1001/jamaoncol.2017.0589. - DOI - PMC - PubMed
    1. Faggiano A., Ferolla P., Grimaldi F., Campana D., Manzoni M., Davi M.V., Bianchi A., Valcavi R., Papini E., Giuffrida D., et al. Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: The NET management study. J. Endocrinol. Invest. 2012;35:817–823. doi: 10.3275/8102. - DOI - PubMed
    1. Falconi M., Eriksson B., Kaltsas G., Bartsch D.K., Capdevila J., Caplin M., Kos-Kudla B., Kwekkeboom D., Rindi G., Kloppel G., et al. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2016;103:153–171. doi: 10.1159/000443171. - DOI - PMC - PubMed
    1. Go V.L., Srihari P., Kamerman Burns L.A. Nutrition and gastroenteropancreatic neuroendocrine tumors. Endocrinol. Metab. Clin. N. Am. 2010;39:827–837. doi: 10.1016/j.ecl.2010.08.003. - DOI - PubMed
    1. Gallo M., Muscogiuri G., Pizza G., Ruggeri R.M., Barrea L., Faggiano A., Colao A., Group N. The management of neuroendocrine tumours: A nutritional viewpoint. Crit. Rev. Food Sci. Nutr. 2017:1–12. doi: 10.1080/10408398.2017.1390729. - DOI - PubMed

MeSH terms

Supplementary concepts